Jiaojiao Jing1, Jan T Kielstein2, Ulla T Schultheiss1, Thomas Sitter3, Stephanie I Titze4, Elke S Schaeffner5, Mara McAdams-DeMarco6, Florian Kronenberg7, Kai-Uwe Eckardt4, Anna Köttgen1. 1. Renal Division, Medical Center-University of Freiburg, Freiburg, Germany. 2. Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany. 3. Department of Medicine, Ludwig-Maximilians-University Hospital, Munich, Germany. 4. Department of Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen, Germany. 5. Division of Nephrology and Intensive Care Medicine, Charité University Medicine, Berlin, Germany. 6. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA. 7. Division of Genetic Epidemiology, Innsbruck Medical University, Innsbruck, Austria.
Abstract
BACKGROUND: Reduced kidney function is a risk factor for hyperuricaemia and gout, but limited information on the burden of gout is available from studies of patients with chronic kidney disease (CKD). We therefore examined the prevalence and correlates of gout in the large prospective observational German Chronic Kidney Disease (GCKD) study. METHODS: Data from 5085 CKD patients aged 18-74 years with an estimated glomerular filtration rate (eGFR) of 30-<60 mL/min/1.73 m(2) or eGFR ≥60 and overt proteinuria at recruitment and non-missing values for self-reported gout, medications and urate measurements from a central laboratory were evaluated. RESULTS: The overall prevalence of gout was 24.3%, and increased from 16.0% in those with eGFR ≥60 mL/min/1.73 m(2) to 35.6% in those with eGFR <30. Of those with self-reported gout, 30.7% of individuals were not currently taking any gout medication and among gout patients on urate lowering therapy, 47.2% still showed hyperuricaemia. Factors associated with gout were serum urate, lower eGFR, advanced age, male sex, higher body mass index and waist-to-hip ratio, higher triglyceride and C-reactive protein (CRP) concentrations, alcohol intake and diuretics use. While lower eGFR categories showed significant associations with gout in multivariable-adjusted models (prevalence ratio 1.46 for eGFR <30 compared with eGFR ≥60, 95% confidence interval 1.21-1.77), associations between gout and higher urinary albumin-to-creatinine ratio in this CKD population were not significant. CONCLUSIONS: Self-reported gout is common among patients with CKD and lower GFR is strongly associated with gout. Pharmacological management of gout in patients with CKD is suboptimal. Prospective follow-up will show whether gout and hyperuricaemia increase the risk of CKD progression and cardiovascular events in the GCKD study.
BACKGROUND: Reduced kidney function is a risk factor for hyperuricaemia and gout, but limited information on the burden of gout is available from studies of patients with chronic kidney disease (CKD). We therefore examined the prevalence and correlates of gout in the large prospective observational German Chronic Kidney Disease (GCKD) study. METHODS: Data from 5085 CKDpatients aged 18-74 years with an estimated glomerular filtration rate (eGFR) of 30-<60 mL/min/1.73 m(2) or eGFR ≥60 and overt proteinuria at recruitment and non-missing values for self-reported gout, medications and urate measurements from a central laboratory were evaluated. RESULTS: The overall prevalence of gout was 24.3%, and increased from 16.0% in those with eGFR ≥60 mL/min/1.73 m(2) to 35.6% in those with eGFR <30. Of those with self-reported gout, 30.7% of individuals were not currently taking any gout medication and among goutpatients on urate lowering therapy, 47.2% still showed hyperuricaemia. Factors associated with gout were serum urate, lower eGFR, advanced age, male sex, higher body mass index and waist-to-hip ratio, higher triglyceride and C-reactive protein (CRP) concentrations, alcohol intake and diuretics use. While lower eGFR categories showed significant associations with gout in multivariable-adjusted models (prevalence ratio 1.46 for eGFR <30 compared with eGFR ≥60, 95% confidence interval 1.21-1.77), associations between gout and higher urinary albumin-to-creatinine ratio in this CKD population were not significant. CONCLUSIONS: Self-reported gout is common among patients with CKD and lower GFR is strongly associated with gout. Pharmacological management of gout in patients with CKD is suboptimal. Prospective follow-up will show whether gout and hyperuricaemia increase the risk of CKD progression and cardiovascular events in the GCKD study.
Authors: Iris J M Disveld; Sahel Zoakman; Tim L Th A Jansen; Gerard A Rongen; Laura B E Kienhorst; Hein J E M Janssens; Jaap Fransen; Matthijs Janssen Journal: Clin Rheumatol Date: 2019-03-30 Impact factor: 2.980
Authors: U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun Journal: Z Rheumatol Date: 2016-08 Impact factor: 1.372
Authors: James R O'Dell; Mary T Brophy; Michael H Pillinger; Tuhina Neogi; Paul M Palevsky; Hongsheng Wu; Anne Davis-Karim; Jeff A Newcomb; Ryan Ferguson; David Pittman; Grant W Cannon; Thomas Taylor; Robert Terkeltaub; Amy C Cannella; Bryant R England; Lindsay N Helget; Ted R Mikuls Journal: NEJM Evid Date: 2022-02-03
Authors: Fruzsina Kotsis; Ulla T Schultheiss; Matthias Wuttke; Pascal Schlosser; Johanna Mielke; Michael S Becker; Peter J Oefner; Edward D Karoly; Robert P Mohney; Kai-Uwe Eckardt; Peggy Sekula; Anna Köttgen Journal: J Am Soc Nephrol Date: 2021-06-17 Impact factor: 14.978